Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
Department of Congenital Heart Diseases, National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
Int J Environ Res Public Health. 2022 Oct 24;19(21):13802. doi: 10.3390/ijerph192113802.
Transcatheter left atrial appendage closure (LAAC) is performed in patients unsuitable for long-term anticoagulation, predominantly due to prior bleeding events. The study aimed to investigate the incidence and predictors of clinically significant bleeding (CSB) post-LAAC.
Consecutive patients after LAAC with an Amplatzer or WATCHMAN device were analyzed (05.2014-11.2019). Bleeding was classified as CSB when associated with at least one of the following: death, ≥2 g/dL hemoglobin drop, ≥2 blood units transfusion, critical anatomic site, or hospitalization/invasive procedure.
Among 195 patients (age 74 (68-80), 43.1% females, HAS-BLED score 2.0 (2.0-3.0)), during median follow-up of 370 (IQR, 358-392) days, there were 15 nonprocedural CSBs in 14 (7.2%) patients. Of those, 9 (60.0%) occurred during postprocedural dual antiplatelet therapy (DAPT) (median 46 (IQR: 16-60) days post-LAAC) vs. 6 (40%) after DAPT discontinuation (median 124 (81-210) days post-LAAC), translating into annualized CSB rates of 14.0% (per patient-year on DAPT) vs. 4.6% (per patient-year without DAPT). In 92.9% (13/14) of patients, the post-LAAC nonprocedural CSB was a recurrence from the same site as bleeding pre-LAAC. In the multivariable model, admission systolic blood pressure (SBP) > 127 mmHg (HR = 10.73, 1.37-84.26, = 0.024), epistaxis history (HR = 5.84, 1.32-25.89, = 0.020), permanent atrial fibrillation (AF) (HR = 4.55, 1.20-17.20, = 0.025), and prior gastrointestinal bleeding (HR = 3.35, 1.01-11.08, = 0.048) predicted post-LAAC CSB.
Nonprocedural CSBs after LAAC, with a similar origin as the pre-LAAC bleedings, were observed predominantly during postprocedural DAPT and predicted by elevated admission SBP, prior epistaxis, permanent AF, and gastrointestinal bleeding history. Whether a more reserved post-LAAC antiplatelet regimen and stringent blood pressure control may improve LAAC outcomes remains to be studied.
经导管左心耳封堵术(LAAC)适用于不适合长期抗凝治疗的患者,主要是由于既往出血事件。本研究旨在探讨 LAAC 术后临床显著出血(CSB)的发生率和预测因素。
对 2014 年 5 月至 2019 年 11 月期间接受 Amplatzer 或 WATCHMAN 装置 LAAC 的连续患者进行分析。当出血与以下至少一项相关时,将其分类为 CSB:死亡、血红蛋白下降≥2g/dL、输注≥2 个单位的血液、关键解剖部位或住院/侵入性操作。
在 195 例患者(年龄 74(68-80)岁,43.1%为女性,HAS-BLED 评分 2.0(2.0-3.0))中,中位随访 370(IQR:358-392)天期间,14 例(7.2%)患者共发生 15 例非手术性 CSB。其中,9 例(60.0%)发生在术后双联抗血小板治疗(DAPT)期间(LAAC 后中位 46(IQR:16-60)天),而 6 例(40%)发生在 DAPT 停药后(LAAC 后中位 124(81-210)天),这意味着 DAPT 期间的年化 CSB 发生率为 14.0%(每位患者每年),而 DAPT 期间无 CSB 的发生率为 4.6%(每位患者每年)。在 92.9%(13/14)的患者中,LAAC 后非手术性 CSB 是与 LAAC 前出血相同部位的复发。在多变量模型中,入院收缩压(SBP)>127mmHg(HR=10.73,1.37-84.26, =0.024)、既往鼻出血史(HR=5.84,1.32-25.89, =0.020)、永久性房颤(AF)(HR=4.55,1.20-17.20, =0.025)和既往胃肠道出血史(HR=3.35,1.01-11.08, =0.048)预测 LAAC 后 CSB。
LAAC 后非手术性 CSB 与 LAAC 前出血具有相似的起源,主要发生在术后 DAPT 期间,可通过入院 SBP 升高、既往鼻出血、永久性 AF 和胃肠道出血史来预测。LAAC 后更保守的抗血小板治疗方案和严格的血压控制是否能改善 LAAC 结局仍有待研究。